Rani Therapeutics news
Rani Therapeutics Holdings, Inc. recently announced the development of a high-capacity oral biologics device known as the RaniPill HC (High Capacity), capable of delivering up to a 500%-plus higher drug payload than Rani’s existing oral biologics capsule. In preclinical testing, RaniPill HC demonstrated successful delivery of adalimumab and achieved high bioavailability.
“The RaniPill HC gives us the potential to deliver a much broader range of biologic drugs with i
Rani Therapeutics has developed an oral biologics device, named RaniPill HC, for the delivery of biologics.
The new device is capable of delivering a drug payload of up to or more than 500% higher compared to the company’s current oral biologics capsule.
A preclinical study of RaniPill HC has been conducted by the company, in whi